Literature DB >> 20595826

Sustained factor VIII production in hemophiliac mice 1 year after engraftment with induced pluripotent stem cell-derived factor VIII producing endothelial cells.

Zaida Alipio, Dorothy M Adcock, Milton Waner, Teresa M-J O, Louis M Fink, David C Ward, Yupo Ma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20595826     DOI： 10.1097/MBC.0b013e32833580e9

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN： 0957-5235            Impact factor:   1.276


× No keyword cloud information.
  3 in total

1.  A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII.

Authors:  Scot A Fahs; Matthew T Hille; Qizhen Shi; Hartmut Weiler; Robert R Montgomery
Journal:  Blood       Date:  2014-04-04       Impact factor: 22.113

Review 2.  Advanced therapies for the treatment of hemophilia: future perspectives.

Authors:  Antonio Liras; Cristina Segovia; Aline S Gabán
Journal:  Orphanet J Rare Dis       Date:  2012-12-13       Impact factor: 4.123

3.  A robust strategy for negative selection of Cre-loxP recombination-based excision of transgenes in induced pluripotent stem cells.

Authors:  Syandan Chakraborty; Nicolas Christoforou; Ali Fattahi; Roland W Herzog; Kam W Leong
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.